Protection against methotrexate toxicity by a soybean protein- and ω-3 fatty acid-containing diet: Comparative study with a casein-containing diet

Oncology Reports

Volumn 12, Issue 1, 2004, Pages 41-45

  Mitsugi, Kenji ^a   Nakamura, Tsuyoshi ^b   Kashiwabara, Norio ^b   Ariyama, Hiroshi ^a   Tanaka, Risa ^a   Baba, Eishi ^a   Nakamura, Minoru ^a   Harada, Mine ^a   Nakano, Shuji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Methotrexate; Soybean; 3 fatty acid

Indexed keywords

CASEIN; METHOTREXATE; OMEGA 3 FATTY ACID; SOYBEAN PROTEIN;

ANIMAL; APPETITE; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; DIET; DRUG EFFECT; INTESTINE MUCOSA; MALE; MICROVILLUS; MOUSE; PATHOLOGY; RAT; SOYBEAN; SPRAGUE DAWLEY RAT;

ANIMALS; APPETITE; BODY WEIGHT; CASEINS; DIET; FATTY ACIDS, OMEGA-3; INTESTINAL MUCOSA; MALE; METHOTREXATE; MICE; MICROVILLI; RATS; RATS, SPRAGUE-DAWLEY; SOYBEAN PROTEINS; SOYBEANS;

EID: 21644455157     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.1.41     Document Type: Article

References (22)

1. Frei E, Jaffe N, Tattersall MHN, Pitman S and Parker L: New approaches to cancer chemotherapy with methotrexate. N Engl J Med 292: 846-851, 1975.
2. Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C and Huvos AG: Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 43: 2163-2177, 1979. (Pubitemid 9246383)
3. Julivet J, Cowan KH, Curt GA, Clendenin NJ and Chabner BA: The pharmacology and clinical use of methotrexate. N Eng J Med 309: 1094-1104, 1983. (Pubitemid 13023161)
4. Stokstad ELR and Jukes TH: Sulfonomides and folic acid antagonists: a historical review. J Nutr 117: 1334-1341, 1987.
5. Robinson JW, Antonioli JA and Vannotti A: The effect of oral methotrexate on the rat intestine. Biochem Pharmacol 15: 1479-1489, 1996.
6. Altmann GG: Changes in the mucosa of the small intestine following methotrexate administration or abdominal Xirradiation. Am J Anat 140: 263-279, 1974.
7. Jeynes BJ and Altmann GG: Light and scanning electron microscopic observations of the effect of sublethal doses of methotrexate on the rat small intestine. Anat Rec 191: 1-17. 1978. (Pubitemid 8345671)
8. Torosian MH, Mullen JL, Miller EE, Zinnser KL and Buzby GP: Reduction of methotrexate toxicity with improved nutritional status in tumor-bearing animals. Cancer 61: 1731-1735, 1988.
9. Fox AD, Kripke SA, Paula JD, Berman JM, Settle RG and Rombeau JL: Effect of glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. J Parenter Enteral Nutr 12: 325-331, 1988.
10. Funk MA and Baker DH: Effect of soy products on methotrexate toxicity in rats. J Nutr 121: 1684-1692, 1991.
11. Gottschlich MM, Jenkins M, Warden GD, Baumer T, Havens P, Snook JT and Alexander JW: Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. J Parenter Enteral Nutr 14: 225-236, 1990. (Pubitemid 20165398)
12. Daly JM, Weintraub FN, Shou J, Rosato EF and Lucia M: Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 221: 327-338, 1995.
13. Kinsella JE, Lokesh B, Broughton S and Whelan J: Dietary polysaturated fatty acid and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 6: 24-44, 1990. (Pubitemid 20105664)
14. Funk MA and Baker DH: Effect of fiber, protein source and time of feeding on methotrexate toxicity in rats. J Nutr 121: 1673-1683, 1991.
15. Kehoe JF, Harvey L and Daly JM: Alteration of chemotherapy toxicity using a chemically defined liquid diet in rats. Cancer Res 46: 4047-4052, 1987. (Pubitemid 16075905)
16. McAnena OJ, Ridge JA and Daly JM: Alteration of methotrexate metabolism in rats by administration of an elemental liquid diet. Cancer 59: 1091-1097, 1987.
17. Shou J, Lieberman MD, Hofmann K, Leon P, Redmond HP, Davies H and Daly JM: Dietary manipulation of methotrexate-induced enterocolitis. J Parenter Enteral Nutr 15: 307-312, 1991.
18. Vanderhoof JA, Blackwood DJ, Mohammadpour HM and Park JHY: Effect of dietary menhaden oil on normal growth and development and on ameliorating mucosal injury in rats. Am J Clin Nutr 54: 346-350, 1991. (Pubitemid 21898941)
19. Hardman WE, Moyer MP and Cameron IL: Fish oil supplementation enhanced CPT-11 (Irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side effects. Br J Cancer 81: 440-448, 1999. (Pubitemid 29458797)
20. Germain E, Lavandier F, Chajes V, Schubnel V, Bonnet P, Lhuillery C and Bougnoux P: Dietary n-3 polyunsaturated fatty acids and oxidants increase rat mammary tumor sensitivity to epirubicin without change in cardiac toxicity. Lipids 34: S203, 1999.
21. Shao Y, Pardini L and Pardini RS: Intervention of transplantable human mammary carcinoma MX-1 chemotherapy with dietary menhaden oil in athymic mice: increased therapeutic effects and decreased toxicity of cyclophosphamide. Nutr Cancer 28: 63-73, 1997. (Pubitemid 27287630)
22. Karmali RA: Historical perspective and potential use of n-3 fatty acids in therapy of cancer cachexia. Nutrition 12: S2-S4, 1996.